AAF
BIO icon

Andra AP-fonden’s Bio-Rad Laboratories Class A BIO Stock Holding History

Andra AP-fonden’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,100
Closed -$2.8M – 420
2024
Q1 		$2.8M Buy
+8,100
New +$2.66M 0.05% 321
2023
Q3 		– Sell
-24,700
Closed -$9.36M – 302
2023
Q2 		$9.36M Buy
24,700
+3,900
+19% +$1.59M 0.24% 132
2023
Q1 		$9.96M Sell
20,800
-5,600
-21% -$2.62M 0.26% 116
2022
Q4 		$11.1M Buy
26,400
+8,900
+51% +$3.59M 0.34% 37
2022
Q3 		$7.3M Buy
17,500
+2,300
+15% +$1.15M 0.24% 151
2022
Q2 		$7.52M Buy
+15,200
New +$7.92M 0.22% 182
2021
Q4 		$6.04M Sell
8,000
-3,500
-30% -$2.62M 0.12% 372
2021
Q3 		$8.58M Buy
11,500
+500
+5% +$375K 0.18% 259
2021
Q2 		$7.09M Buy
11,000
+1,700
+18% +$1.03M 0.14% 345
2021
Q1 		$5.31M Sell
9,300
-3,700
-28% -$2.19M 0.12% 419
2020
Q4 		$7.58M Sell
13,000
-1,300
-9% -$740K 0.17% 293
2020
Q3 		$7.37M Sell
14,300
-3,700
-21% -$1.87M 0.2% 182
2020
Q2 		$8.13M Buy
18,000
+4,100
+29% +$1.81M 0.24% 69
2020
Q1 		$4.87M Sell
13,900
-200
-1% -$73.5K 0.18% 199
2019
Q4 		$5.22M Buy
+14,100
New +$4.97M 0.15% 350

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Andra AP-fonden's BIO Position: Q2 2024 in Review

Andra AP-fonden sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2024, closing a stake of 8,100 shares — an estimated $2.8M sold.

Andra AP-fonden first reported a position in BIO in Q4 2019 and held it in 15 quarters. The position peaked at $11.1M in Q4 2022. 440 funds tracked by Wall St. Rank hold BIO as of Q2 2024.

  • Andra AP-fonden reported no remaining Bio-Rad Laboratories Class A position as of Q2 2024 after selling out during the quarter.
  • Andra AP-fonden sold 8,100 Bio-Rad Laboratories Class A shares in Q2 2024, an estimated $2.8M.
  • Andra AP-fonden first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 15 quarters.
  • Andra AP-fonden's Bio-Rad Laboratories Class A position peaked at $11.1M in Q4 2022.
  • 440 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2024.

Based on Andra AP-fonden's 13F filing for Q2 2024, filed 7 Aug 2024.